You are here
Lipella Pharmaceuticals Inc.
UEI: JBVNWFNEEV59
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Bladder drug delivery using intravesical liposomes to treat overactive bladder
Amount: $100,000.00DESCRIPTION (provided by applicant): Lipella Pharmaceutical Inc has been successful with development of intravesical liposome for painful bladder syndrome/Interstitial cystitis (PBS/IC). Through SB ...
SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
Developing Intravesical Liposomes for Interstitial Cystitis
Amount: $740,688.00DESCRIPTION (provided by applicant): LP08 is a novel intravesical treatment for interstitial cystitis (IC), a poorly understood chronic disorder of unknown etiology consisting of irritative bladder sy ...
STTRPhase I2009Department of Health and Human Services National Institutes of Health -
Intravesical Liposome Treatment for Interstitial Cystitis
Amount: $750,000.00DESCRIPTION (provided by applicant): Interstitial cystitis (IC) is a chronic, severely debilitating disease of the urinary bladder. It can be described as a chronic inflammatory condition of the bladd ...
SBIRPhase II2008Department of Health and Human Services National Institutes of Health -
Intravesical Liposome Treatment for Interstitial Cystitis
Amount: $99,617.00DESCRIPTION (provided by applicant): Interstitial cystitis (IC) is a chronic, severely debilitating disease of the urinary bladder. It can be described as a chronic inflammatory condition of the bladd ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health